Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth A Jacobson

Showing results (241-250 of 599) with videos related to

Pageof 60
Sort By:
Mediators of Inflammation|November 7, 2014
A₃ adenosine receptor allosteric modulator induces an anti-inflammatory effect: in vivo studies and molecular mechanism of actionShira Cohen, Faina Barer, Sara Bar-Yehuda, et al.
Scientific Reports|May 26, 2018
Salvianolic acids from antithrombotic Traditional Chinese Medicine Danshen are antagonists of human P2Y<sub>1</sub> and P2Y<sub>12</sub> receptorsXuyang Liu, Zhan-Guo Gao, Yiran Wu, et al.
Drug Development Research|July 5, 2022
Acyl-Hydrazide Derivatives of a Xanthine Carboxylic Congener (XCC) as Selective Antagonists at Human A<sub>2B</sub> Adenosine ReceptorsYong-Chul Kim, Yishai Karton, Xiao-Duo Ji, et al.
Chemical Science|June 24, 2021
Ligand design by targeting a binding site waterPierre Matricon, R Rama Suresh, Zhan-Guo Gao, et al.
ACS Medicinal Chemistry Letters|August 23, 2011
Truncated (N)-Methanocarba Nucleosides as A(1) Adenosine Receptor Agonists and Partial Agonists: Overcoming Lack of a Recognition ElementDilip K Tosh, Khai Phan, Francesca Deflorian, et al.
Nucleic Acids Symposium Series (2004)|December 8, 2006
Development of potent and selective human A3 adenosine receptor agonistsLak Shin Jeong, Hyuk Woo Lee, Kenneth A Jacobson, et al.
Plos One|November 28, 2012
Limits of ligand selectivity from docking to models: in silico screening for A(1) adenosine receptor antagonistsPeter Kolb, Khai Phan, Zhan-Guo Gao, et al.
Purinergic Signalling|February 13, 2023
In vivo phenotypic validation of adenosine receptor-dependent activity of non-adenosine drugsCuiying Xiao, Oksana Gavrilova, Naili Liu, et al.
Drug Development Research|January 17, 2024
Species Differences in Ligand Affinity at Central A<sub>3</sub>-Adenosine ReceptorsXiao-Duo Ji, Dag von Lubitz, Mark E Olah, et al.
Purinergic Signalling|July 5, 2008
Application of the functionalized congener approach to dendrimer-based signaling agents acting through A(2A) adenosine receptorsYoonkyung Kim, Athena M Klutz, Béatrice Hechler, et al.
Pageof 60

Showing results (241-250 of 599) with videos related to

Sort By:
Pageof 60
Mediators of Inflammation|November 7, 2014
A₃ adenosine receptor allosteric modulator induces an anti-inflammatory effect: in vivo studies and molecular mechanism of actionShira Cohen, Faina Barer, Sara Bar-Yehuda, et al.
Scientific Reports|May 26, 2018
Salvianolic acids from antithrombotic Traditional Chinese Medicine Danshen are antagonists of human P2Y<sub>1</sub> and P2Y<sub>12</sub> receptorsXuyang Liu, Zhan-Guo Gao, Yiran Wu, et al.
Drug Development Research|July 5, 2022
Acyl-Hydrazide Derivatives of a Xanthine Carboxylic Congener (XCC) as Selective Antagonists at Human A<sub>2B</sub> Adenosine ReceptorsYong-Chul Kim, Yishai Karton, Xiao-Duo Ji, et al.
Chemical Science|June 24, 2021
Ligand design by targeting a binding site waterPierre Matricon, R Rama Suresh, Zhan-Guo Gao, et al.
ACS Medicinal Chemistry Letters|August 23, 2011
Truncated (N)-Methanocarba Nucleosides as A(1) Adenosine Receptor Agonists and Partial Agonists: Overcoming Lack of a Recognition ElementDilip K Tosh, Khai Phan, Francesca Deflorian, et al.
Nucleic Acids Symposium Series (2004)|December 8, 2006
Development of potent and selective human A3 adenosine receptor agonistsLak Shin Jeong, Hyuk Woo Lee, Kenneth A Jacobson, et al.
Plos One|November 28, 2012
Limits of ligand selectivity from docking to models: in silico screening for A(1) adenosine receptor antagonistsPeter Kolb, Khai Phan, Zhan-Guo Gao, et al.
Purinergic Signalling|February 13, 2023
In vivo phenotypic validation of adenosine receptor-dependent activity of non-adenosine drugsCuiying Xiao, Oksana Gavrilova, Naili Liu, et al.
Drug Development Research|January 17, 2024
Species Differences in Ligand Affinity at Central A<sub>3</sub>-Adenosine ReceptorsXiao-Duo Ji, Dag von Lubitz, Mark E Olah, et al.
Purinergic Signalling|July 5, 2008
Application of the functionalized congener approach to dendrimer-based signaling agents acting through A(2A) adenosine receptorsYoonkyung Kim, Athena M Klutz, Béatrice Hechler, et al.
Pageof 60